Viking shares jump after positive early data on oral obesity pill; Lilly, Novo drop

Bathroom scale, measuring tape and space for text on white wooden floor, top view. Weight loss concept

Liudmila Chernetska/iStock via Getty Images

Shares of Viking Therapeutics (NASDAQ:VKTX) jumped 22% Monday morning after the biotech firm reported promising results for its experimental obesity pill, with increased weight loss observed at higher doses.

Patients on 100-milligram doses of Viking’s (VKTX) VK2735 lost an

Leave a Reply

Your email address will not be published. Required fields are marked *